X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs CIPLA - Comparison Results

LUPIN    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN CIPLA LUPIN/
CIPLA
 
P/E (TTM) x 45.0 35.1 128.2% View Chart
P/BV x 2.8 3.2 87.3% View Chart
Dividend Yield % 0.6 0.5 112.3%  

Financials

 LUPIN   CIPLA
EQUITY SHARE DATA
    LUPIN
Mar-18
CIPLA
Mar-18
LUPIN/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,465663 221.0%   
Low Rs727479 151.8%   
Sales per share (Unadj.) Rs349.6189.0 184.9%  
Earnings per share (Unadj.) Rs5.617.6 31.6%  
Cash flow per share (Unadj.) Rs29.634.0 86.9%  
Dividends per share (Unadj.) Rs5.003.00 166.7%  
Dividend yield (eoy) %0.50.5 86.8%  
Book value per share (Unadj.) Rs300.3176.7 169.9%  
Shares outstanding (eoy) m452.08805.12 56.2%   
Bonus/Rights/Conversions ESOPSESOP-  
Price / Sales ratio x3.13.0 103.8%   
Avg P/E ratio x197.232.5 607.7%  
P/CF ratio (eoy) x37.116.8 220.8%  
Price / Book Value ratio x3.63.2 113.0%  
Dividend payout %90.017.1 527.6%   
Avg Mkt Cap Rs m495,502459,724 107.8%   
No. of employees `00017.023.6 72.2%   
Total wages/salary Rs m28,64726,901 106.5%   
Avg. sales/employee Rs Th9,273.66,446.1 143.9%   
Avg. wages/employee Rs Th1,681.01,139.4 147.5%   
Avg. net profit/employee Rs Th147.4600.0 24.6%   
INCOME DATA
Net Sales Rs m158,042152,193 103.8%  
Other income Rs m1,5043,577 42.0%   
Total revenues Rs m159,545155,769 102.4%   
Gross profit Rs m31,47528,264 111.4%  
Depreciation Rs m10,85913,228 82.1%   
Interest Rs m2,0441,142 178.9%   
Profit before tax Rs m20,07617,470 114.9%   
Minority Interest Rs m-710-   
Prior Period Items Rs m35-28 -126.6%   
Extraordinary Inc (Exp) Rs m-14,644-775 1,889.0%   
Tax Rs m2,8852,501 115.3%   
Profit after tax Rs m2,51314,166 17.7%  
Gross profit margin %19.918.6 107.2%  
Effective tax rate %14.414.3 100.4%   
Net profit margin %1.69.3 17.1%  
BALANCE SHEET DATA
Current assets Rs m122,095108,141 112.9%   
Current liabilities Rs m50,95638,322 133.0%   
Net working cap to sales %45.045.9 98.1%  
Current ratio x2.42.8 84.9%  
Inventory Days Days8597 87.2%  
Debtors Days Days12074 161.2%  
Net fixed assets Rs m129,876109,411 118.7%   
Share capital Rs m9041,610 56.2%   
"Free" reserves Rs m134,866140,682 95.9%   
Net worth Rs m135,771142,292 95.4%   
Long term debt Rs m64,24536,621 175.4%   
Total assets Rs m263,054228,606 115.1%  
Interest coverage x10.816.3 66.4%   
Debt to equity ratio x0.50.3 183.9%  
Sales to assets ratio x0.60.7 90.2%   
Return on assets %1.76.7 25.9%  
Return on equity %1.910.0 18.6%  
Return on capital %3.710.0 37.4%  
Exports to sales %032.8 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA49,883 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53,14151,691 102.8%   
Fx outflow Rs m19,33521,033 91.9%   
Net fx Rs m33,80730,658 110.3%   
CASH FLOW
From Operations Rs m17,51214,628 119.7%  
From Investments Rs m-14,073-8,540 164.8%  
From Financial Activity Rs m-14,921-3,855 387.1%  
Net Cashflow Rs m-11,4822,431 -472.3%  

Share Holding

Indian Promoters % 46.6 16.0 291.3%  
Foreign collaborators % 0.2 20.8 1.0%  
Indian inst/Mut Fund % 11.3 12.2 92.6%  
FIIs % 31.9 23.7 134.6%  
ADR/GDR % 0.0 1.1 -  
Free float % 10.1 26.2 38.5%  
Shareholders   98,259 161,166 61.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare LUPIN With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

CIPLA Announces Quarterly Results (3QFY19); Net Profit Up 17.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, CIPLA has posted a net profit of Rs 3 bn (up 17.5% YoY). Sales on the other hand came in at Rs 40 bn (up 2.4% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (2QFY19); Net Profit Down 15.8% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, CIPLA has posted a net profit of Rs 4 bn (down 15.8% YoY). Sales on the other hand came in at Rs 40 bn (down 1.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Apr 18, 2019 (Close)

TRACK LUPIN

LUPIN - ORCHID PHARMA LTD COMPARISON

COMPARE LUPIN WITH

MARKET STATS